Experimental treatment uses modified stem cells to fight cancer

Daniel Apodaca is a 25-year-old film student at UCLA. He's also the first patient in a clinical trial that's testing a treatment using genetically modified bone marrow stem cells to fight cancer.

Posted: Jul 21, 2018 4:41 PM
Updated: Jul 21, 2018 5:01 PM

A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient's own body into a powerful weapon against cancer.

Researchers at the university's Jonsson Comprehensive Cancer Center are reinforcing the immune system's foundation by genetically modifying bone marrow stem cells, the cellular factories that power immune responses. By arming those cells with receptors that recognize cancer, researchers hope a patient's body will cure itself from the inside out.

Dr. Antoni Ribas, who is leading the trial, started working on cancer immunotherapy -- treatments that alter a patient's immune response to fend off cancer -- more than 20 years ago. He played a key role in the clinical development of Keytruda, Merck's popular immunotherapy drug used to treat several types of cancer including some types of melanoma (a type of skin cancer), Hodgkin's disease, some head and neck cancers, some non-small cell lung cancers, and some colorectal cancers. Now he's turning his attention to another therapy he finds especially exciting.

The immune system defends the body against sickness. T-cells play an integral role. They're a type of white blood cell that seeks out and destroys diseased cells. The trouble is, T-cells don't recognize cancerous cells as an adversary, leaving the body vulnerable.

Researchers already know how to get around that by extracting T-cells and adding the genetic code for receptors that detect cancer. The problem? Eventually those super-powered T-cells stop working. "We realized the immune system cells that we give back have a limited life span," Ribas said.

That's where the UCLA trial comes in.

Bone marrow stem cells are the factories that produce new T-cells. But rather than simply genetically modifying T-cells, Ribas is modifying the bone marrow stem cells that make them. In other words, he's modifying the car factory, not just the car.

The result, in theory, is a lifetime supply of cancer-fighting T-cells and, hopefully, a more cancer-resistant immune system. Testing that theory will require years of clinical trials. Daniel Apodaca, 25-year-old UCLA student who has epithelioid sarcoma, a rare, soft tissue cancer that grows slowly, became the trial's first patient in April.

"I didn't have any options before," Apodaca told CNNMoney. "So just having an option in general, I feel really lucky."

Ribas said doctors extracted some of Apodaca's bone marrow stem cells along with a batch of T-cells and modified them in the lab. Chemotherapy helped eradicate his existing immune system cells, making room for the new and improved ones. The immune system reboot kept Apodaca in a sterile hospital environment for three weeks. When he left on April 24th with his reprogrammed immune system, doctors called it his second birthday. But it will be years before they can definitively say the treatment worked.

Beyond the uncertainty inherent in any experimental treatment, immunotherapies come with risks and side effects, such as colitis, or colon inflammation, infection, or even a severe or fatal allergic reaction, although that's rare. And cell therapy carries the possibility that the upgraded immune system could attack healthy tissues, said Fred Ramsdell, Vice President of Research at the Parker Institute for Cancer Immunotherapy.

"As we try to amp up the immune system, we do run the risk of having the immune system recognize some of our normal tissues," and attack them, he said.

If that happens, "we'll pull the safety mechanism," Ribas said. "We [insert] a gene that allows us to kill them if they become bad."

Despite the risk, the therapy could advance the field of immunotherapy, Ramsdell said. "We need to find ways to sustain the effect of adapted cell therapies," he said. "This trial is pushing the envelope."

Achieving that progress took more than a decade of research and millions of dollars, Ribas said. The California Institute for Regenerative Medicine, a taxpayer-funded research organization, financed the trial with a $20 million grant.

Ribas estimates the therapy could cost hundreds of thousands of dollars per patient. And even if it works, big questions remain about its wider application. The key to an effective targeted immunotherapy is detecting the unique signature of a patient's specific cancer and matching it with a receptor that doctors can add to a T-cell. That's how the modified T-cell knows to attack the cancerous cells, not healthy cells. But the process of matching cancer signatures and receptors has proven difficult, and the list of matches remains relatively short.

"Our first attempt is targeting in particular two cancers, sarcomas and melanomas, because they have a protein called NY-ESO-1 that can be efficiently targeted with a receptor that we have," Ribas said. "Potentially, we could do more, but every time we use a new receptor we would have to go back to the beginning."

For now, Apodaca is responding well enough to visit his girlfriend who is finishing up school in Spain. And he manages to stay optimistic about the future. "Hopefully I become the golden child for this amazing scientific movement," he said. "I look to see some real progress in medicine and for oncology, potentially for all subtypes of cancer."

That movement remains a long way off. The therapy faces several more clinical trials and rigorous FDA review before it enters widespread use. That is, if it works. And that's a big if. But such is the nature of medical research. "That's where we push the limits of science," Ribas said. "If we don't do things like this, then we don't advance."

Indiana Coronavirus Cases

Data is updated nightly.

Cases: 312521

Reported Deaths: 5498
CountyCasesDeaths
Marion42641849
Lake27152455
Allen18010298
Elkhart17177221
St. Joseph16799229
Hamilton13011167
Vanderburgh9751120
Tippecanoe858727
Porter827986
Johnson6389165
Hendricks6098157
Vigo608384
Monroe536750
Clark515077
Madison5060122
Delaware4905103
LaPorte465595
Kosciusko462339
Howard344277
Warrick325672
Bartholomew316863
Floyd316277
Wayne307770
Cass299931
Marshall299144
Grant272550
Noble255046
Hancock253852
Henry247537
Boone244554
Dubois237931
Dearborn219030
Jackson215534
Morgan210843
Knox187819
Gibson186925
Shelby182155
Clinton180321
DeKalb177831
Lawrence177648
Adams168222
Miami162614
Wabash162521
Daviess156443
Fayette149234
Steuben147113
Jasper144412
Harrison142924
LaGrange142630
Montgomery142127
Whitley137114
Ripley132115
Huntington127410
Decatur126143
Putnam124627
Randolph124519
Wells124429
White123222
Clay122523
Posey122116
Jefferson118816
Scott109020
Greene102653
Jay99013
Sullivan96416
Starke92021
Jennings85314
Fulton84518
Spencer8378
Perry82521
Fountain7798
Washington7527
Franklin69927
Carroll68613
Orange67328
Vermillion6243
Owen6087
Tipton57627
Parke5706
Newton56312
Rush5438
Blackford53412
Pike50919
Pulaski39515
Martin3585
Brown3424
Benton3402
Crawford2941
Union2702
Switzerland2575
Warren2382
Ohio2317
Unassigned0266

Ohio Coronavirus Cases

Data is updated nightly.

Cases: 382743

Reported Deaths: 6274
CountyCasesDeaths
Franklin51161671
Cuyahoga37222743
Hamilton30493372
Montgomery20518236
Butler15199148
Lucas14566417
Summit13933327
Stark9193206
Warren841976
Mahoning7530300
Lake710067
Lorain6690106
Clermont593651
Delaware572537
Licking564577
Trumbull5584147
Fairfield554464
Greene538066
Clark5218101
Allen494989
Marion476759
Medina471657
Wood4598107
Miami437568
Pickaway404048
Portage358972
Columbiana357698
Tuscarawas342667
Richland328539
Wayne327394
Mercer296047
Muskingum252510
Hancock245940
Ross244559
Auglaize236435
Darke232560
Erie230268
Putnam229449
Ashtabula228354
Geauga211851
Scioto200616
Union19668
Shelby194017
Lawrence193039
Athens19134
Seneca182919
Belmont170229
Madison163119
Sandusky157729
Preble156521
Huron155519
Defiance144823
Holmes140439
Logan133517
Knox131718
Fulton128726
Jefferson128613
Crawford126817
Washington125227
Ottawa124530
Clinton109115
Williams10799
Ashland107825
Highland103718
Brown10135
Henry101323
Hardin99719
Champaign9825
Van Wert97318
Jackson96212
Fayette92717
Morrow9202
Guernsey89314
Coshocton85215
Perry82912
Adams80313
Pike7661
Gallia76513
Wyandot73217
Paulding66511
Hocking64516
Noble62224
Carroll48810
Meigs39612
Monroe32321
Morgan2685
Vinton2246
Harrison2193
Unassigned00
Fort Wayne
Overcast
45° wxIcon
Hi: 46° Lo: 36°
Feels Like: 39°
Angola
Overcast
43° wxIcon
Hi: 45° Lo: 35°
Feels Like: 37°
Huntington
Overcast
44° wxIcon
Hi: 46° Lo: 35°
Feels Like: 38°
Decatur
Overcast
46° wxIcon
Hi: 47° Lo: 37°
Feels Like: 41°
Van Wert
Overcast
46° wxIcon
Hi: 48° Lo: 38°
Feels Like: 41°
Cloudy Thanksgiving
WFFT Radar
WFFT Temperatures
WFFT National

Community Events